|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q11685297
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000015.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q11685297
|
|
024
|
|
|
‡a
0000-0002-5720-769X
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q11685297
|
|
043
|
|
|
‡c
ES
|
|
046
|
|
|
‡f
19521009
|
|
100
|
0 |
|
‡a
Jordi Camí i Morell
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Jordi Camí
‡c
Spanish academic; Professor of Pharmacology
‡9
en
|
|
400
|
0 |
|
‡a
Jordi Camí i Morell
‡c
metge i professor universitari català
‡9
ca
|
|
400
|
0 |
|
‡a
Jordi Camí
‡c
médico y catedrático español
‡9
es
|
|
400
|
0 |
|
‡a
Jordi Camí
‡c
Spaans arts
‡9
nl
|
|
400
|
0 |
|
‡a
Jordi Camí i Morell
‡c
médecin et pharmacologue catalan
‡9
fr
|
|
670
|
|
|
‡a
Author's Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.
|
|
670
|
|
|
‡a
Author's MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.
|
|
670
|
|
|
‡a
Author's On the cognitive bases of illusionism
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/DNB|1263136028
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000117974133
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNC|a10057882
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNE|XX1723053
|
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/305991325
|
|
670
|
|
|
‡a
wikidata site links
‡u
https://ca.wikipedia.org/wiki/Jordi_Camí_i_Morell
|
|
670
|
|
|
‡a
wikidata site links
‡u
https://en.wikipedia.org/wiki/Jordi_Camí
|
|
670
|
|
|
‡a
wikidata site links
‡u
https://es.wikipedia.org/wiki/Jordi_Camí
|
|
909
|
|
|
‡a
(orcid) 000000025720769x
‡9
1
|
|
919
|
|
|
‡a
onthecognitivebasesofillusionism
‡A
On the cognitive bases of illusionism
‡9
1
|
|
919
|
|
|
‡a
mdmaecstasypharmacokineticsinacyp2d6poormetaboliserandin9cyp2d6extensivemetabolisers
‡A
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.
‡9
1
|
|
919
|
|
|
‡a
humanpharmacologyof34methylenedioxymethamphetaminemdmaecstasyafterrepeateddosestaken4haparthumanpharmacologyofmdmaafterrepeateddosestaken4hapart
‡A
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
947
|
|
|
‡a
ES
‡9
1
|
|
996
|
|
|
‡2
BNC|981059737101506706
|
|
996
|
|
|
‡2
BNE|XX1638719
|
|
996
|
|
|
‡2
NUKAT|nx2023074414
|
|
996
|
|
|
‡2
ISNI|0000000076997063
|
|
996
|
|
|
‡2
LC|n 2014182058
|
|
996
|
|
|
‡2
BNE|XX1723053
|
|
996
|
|
|
‡2
DNB|1051125650
|
|
996
|
|
|
‡2
BNE|XX1707895
|
|
996
|
|
|
‡2
BNC|981058613672306706
|
|
996
|
|
|
‡2
BNC|981058509692406706
|
|
996
|
|
|
‡2
LC|n 2017010387
|
|
996
|
|
|
‡2
NII|DA18498207
|
|
996
|
|
|
‡2
BNF|16731833
|
|
996
|
|
|
‡2
LC|n 2021067319
|
|
996
|
|
|
‡2
BNC|981058519987706706
|
|
996
|
|
|
‡2
BNE|XX4886116
|
|
996
|
|
|
‡2
BNC|981058607468106706
|
|
997
|
|
|
‡a
1952 0 lived 1009 0
‡9
1
|
|
998
|
|
|
‡a
Camí, Jordi
‡2
DNB|1263136028
‡3
suggested
‡3
single date
‡3
standard number
|
|
998
|
|
|
‡a
Camí, Jordi
‡2
BNE|XX1723053
‡3
suggested
‡3
single date
|
|
998
|
|
|
‡a
Camí, Jordi,
‡2
LC|n 2021067319
‡3
single date
|
|
998
|
|
|
‡a
Camí, Jordi,
‡2
BNC|981058511680706706
‡3
single date
‡3
standard number
|
